Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 30:13:3179-3185.
doi: 10.2147/RMHP.S265264. eCollection 2020.

Implications of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: A Proposed Observational Investigation by the Fail-to-Refill Project

Luca Degli Esposti  1 , Stefano Buda  1 , Carmela Nappi  1 , Daniela Paoli  2 , Valentina Perrone  1 ; Network Health-DB
Affiliations

Implications of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: A Proposed Observational Investigation by the Fail-to-Refill Project

Luca Degli Esposti et al. Risk Manag Healthc Policy. .

Abstract

Poor medication adherence leads to worsening of clinical outcomes and increases healthcare costs, especially in the context of chronic conditions. The effects of new COVID-19 infection and the measures taken in response to the outbreak are further increasing the concerns about medication adherence. Patients with chronic diseases, many of whom are older adults, have been strongly recommended to stay at home and avoid social contacts even with family members, who often provide support for regular use of therapies. Moreover, the mobilization of health personnel to the frontline of the COVID-19 infection could limit access to healthcare services. Within the Health-DB project, the Fail-To-Refill monitoring system was designed to evaluate the lack of adherence to chronic therapies in Italian clinical practice settings. Considering the date and dose coverage of last prescription, all patients due to refill this prescription for a chronic therapy in the last month were identified, and it was verified if they had the refill. The proposed future analysis, based on the data linkage between the current administrative flows of the Italian Local Health Units involved, will be carried out on a monthly basis from the beginning of the infection, and the "post-Covid-19" results will be compared with "pre-COVID-19" results, calculated for the last three years for patients with chronic therapies. Preliminary data herein presented showed a trend of increased failed refill during the months of lockdown for lipid-lowering and biologic therapies. The pre-COVID-19 trend compared to that of post-COVID-19 in the next months will be useful to estimate the percentage of failure to refill truly related to COVID-19 and on the measures adopted. The identification of patients that do not refill their prescriptions allows healthcare professionals to put in place actions aimed to promptly correct the lack of adherence, thus reducing the associated negative outcomes.

Keywords: SARS-CoV-2; chronic disease; real-world data; treatment adherence.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Percentage of failed refill of lipid-lowering therapies prior to COVID-19 outbreak and in the first months afterwards (highlighted in red boxes).
Figure 2
Figure 2
Percentage of failed refill of biologic therapies prior to COVID-19 outbreak and in the first months afterwards (highlighted in red boxes).
See this image and copyright information in PMC

References

    1. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003. World Health Organization, eds. - PubMed
    1. Brown MT, Bussell JK. Medication adherence: who cares? Mayo Clin Proc. 2011;86(4):304–314. doi:10.4065/mcp.2010.0575 - DOI - PMC - PubMed
    1. Boswell KA, Cook CL, Burch S, Eaddy M, Cantrell C. Associating medication adherence with improved outcomes: A systematic literature review. American J Pharmacy Benefits. 2012;4:e97–e108.
    1. Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;7:675–682. doi:10.2147/PPA.S29549 - DOI - PMC - PubMed
    1. Michel B, Egan Brent M. Adherence in hypertension. Circ Res. 2019;124(7):1124–1140. doi:10.1161/CIRCRESAHA.118.313220 - DOI - PubMed